Managing scleroderma symptoms through a team approach

Working with trained peers on a health routine is effective in building a strong and supportive community

2:45 PM

Author | Valerie Goodwin

Effects of Resilience-Building Energy Management Program on Fatigue in Systemic Sclerosis
Credit: ACR

For patients with scleroderma, managing fatigue and sticking to a health routine can be challenging. Symptoms can be burdensome and overwhelming which make a daily schedule feel daunting.

But research published in the Arthritis Care and Research Journal from Michigan Medicine found that scleroderma patients made significant strides when working with trained peer health coaches in adhering to wellness routines, leading to resilience and improvements in fatigue, pain and depressive symptoms.

About the study

Participants in the clinical trial were randomized to either receive the Resilience-building Energy management to Enhance Wellbeing treatment, referred to as RENEW, or to participate in a control group where they managed symptoms as they usually would.

Participants in the RENEW group downloaded a mobile app that presented information on different health topics pertaining to patients with scleroderma.

In the RENEW app, participants were able to set goals and keep track of their progress.

The participants also spoke with trained peer health coaches regularly throughout the study about their personal goals for managing their symptoms as well as the obstacles they were facing when it came to reaching those goals.

“The peer health coaches were not health care providers, but instead people who also have scleroderma and have faced many of the same daily challenges,” said Susan Murphy, ScD, OTR, a professor of physical medicine and rehabilitation and a researcher in the division of rheumatology at University of Michigan Health as well as the lead author of the study.

“We found that having peer health coaches that had similar experiences with fatigue and pain helped participants feel understood when it came to talking about their personal obstacles for creating health routines.

“Scleroderma is a rare condition, and peer health coaches were skilled at helping others adjust their goals to meet their current needs given their own experiences having scleroderma.”

Each peer health coach met with their participant nine times over the course of 12 weeks.

The peer health coach and participant would discuss the participant’s goals, set a plan to achieve these goals, discuss their progress or adjustments that needed to be made and have peer to peer conversations about their experiences with scleroderma.

The peer health coaches also worked with participants to make sure that their health routine meshed into the daily life and activities of the participant.

This included becoming more active, being able to participate in pleasurable activities, and relaxing.

“Keeping a routine to manage pain and fatigue is important for those with scleroderma, but the symptoms of scleroderma make this hard to do for many patients,” said Murphy.

“Scleroderma patients need support when finding ways to manage their fatigue and pain. Eliminating the power dynamic of the doctor and the patient and having peer health coaches gave participants new insight into different ways they could manage their symptoms and helped them feel supported in their journey by creating a community connection.”

Treating patients with RENEW Scleroderma

Murphy and her team aim to make the RENEW Scleroderma service available for public use to help patients with scleroderma around the country, but that’s still in the works.

The team also thinks this approach could be extended to people who have other chronic conditions.

“The goal is to help scleroderma patients enjoy their life with more energy and less pain,” said Murphy.

“We also found that people who participated in RENEW had better moods and felt they were more equipped to adapt when things got rough.

“Programs like RENEW may be an important tool to help patients manage their condition over time.”

Additional authors include: Susan L. Murphy Sc.D., from the Department of Physical Medicine & Rehabilitation, University of Michigan, USA, Michigan Scleroderma Program, University of Michigan, Ann Arbor, Michigan, USA, and the Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA. Yen T. Chen Ph.D. and Dinesh Khanna M.D., M.Sc. from the Michigan Scleroderma Program, University of Michigan, Ann Arbor, Michigan, USA as well as the Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA. Mary Alore M.B.A., Sheri Hicks M.A. and Adam Pape B.S. from the Michigan Scleroderma Program, University of Michigan, Ann Arbor, Michigan, USA. Anna L. Kratz Ph.D., Daniel Whibley Ph.D., Alexandra E. Harper Ph.D., Gina Jay Ph.D. and Shannen Bolde M.P.H. from the Department of Physical Medicine & Rehabilitation, University of Michigan, USA. Suiyuan Huang M.S. from the Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA. Afton L. Hassett Psy.D. from the Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.

Funding for this project was provided by the Rheumatology Research Foundation Innovative Research Award. Development of the mobile application used in this trial was supported by the App Factory to Support Health and Function of People with Disabilities funded by a grant from the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR) in the US Department of Health and Human Services under (Grant # 90DPHF0004).

Paper cited: “Effects of a Resilience-Building Energy Management Program on Fatigue and Other Symptoms in Systemic Sclerosis: A Randomized Controlled Trial,” American College of Rheumatology. DOI: 10.1002/acr.25253


More Articles About:

Basic Science and Laboratory Research chronic pain Pain Occupational Health Exercise Depression
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

graphic of red green orange blue close up of inside of body and insides shaking
Health Lab

Pain, psychological factors and physical function closely linked in people with systemic sclerosis

For many people living with chronic conditions like systemic sclerosis, pain can be persistent, unpredictable, and difficult to manage leading to a strong impact on a patient’s mental health.
Michelle Hastings, Ph.D. and lab member look at molecule on computer screen.
News Release

$3.9 million NIH grant to fuel U-M effort to develop first targeted therapy for fatal childhood brain disorder

A team led by Dr. Michelle Hastings will advance a new RNA-based medicine for the most common form of CLN3 Batten disease toward clinical trials
Father comforts sick child
News Release

15 years of data will help uncover how flu spreads—and how to reduce its impact

$14.2-million NIH award to University of Michigan funds research to untangle intricacies of person-to-person flu transmission—and reduce illness, deaths, economic losses
A stylized digital image of an X-ray of a human skeleton superimposed on a strand of DNA
Health Lab

Bigger data reveals the second, third and fourth switches controlling a gene

A University of Michigan study reveals the untapped potential of the NIH-sponsored Trans-Omics for Precision Medicine, or TOPMed, program.
layers of skin pink to yellow
Health Lab

Study outlines a new framework for direct cell reprogramming

In a new paper published in the journal iScience, Lindsey Muir, Ph.D. and her lab at Michigan Medicine propose a framework for direct cell reprogramming.
cells close up blue and green background microscope
Health Lab

Engineered nanoparticles sensitize gliomas to radiotherapy

University of Michigan researchers discovered a new pathway that sensitizes mIDH1 gliomas to radiation in human and mouse mIDH1 glioma cells and mouse models, paving the way for phase 1 clinical trials in humans